Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. Sana shares a vision of repairing and controlling genes, replacing missing or damaged cells, and making its therapies broadly available to patients. Sana is more than 250 people working together to create an enduring company that changes how the world treats disease. Sana has operations in Seattle, Cambridge, and South San Francisco.
| Market Cap | 3.511 Billion | Shares Outstanding | 187.676 Million | Avg 30-day Volume | 545.174 Thousand | ||
| P/E Ratio | Dividend Yield | EPS | |||||
| Price/Sales | Debt to Equity | EBITDA | |||||
| Price to Book Value | 0.0 | Forward PE | -0.05 | Enterprise Value | |||
| Total Cash | Current Debt | Gross Profit | |||||
| BETA | 0.0 | 52-week High/Low | 44.6 / 16.28 | Next Earnings Date | 2021-08-04 | Price to Cash FLow (P/CF) | -9999999.0 |
| Data provided by IEX Cloud | |||||||
| Q1 2021 | All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|---|---|---|---|---|---|
| In top 10: | 2 | 0 | 0 (0.0%) | No data | ||
| Funds Holding: | 78 | 0 | 22 (1.29%) | No data | ||
| 13F shares: | 88.859 Million | 0 | 6.835 Million | No data | ||
| % Ownership | 47.3901 | 3.6452 | No data | |||
| New Positions: | 77 | 22 | No data | |||
| Increased Positions | No data | |||||
| Closed Positions | No data | |||||
| Reduced Positions | No data | |||||
| Total Calls | No data | |||||
| Total Puts | No data | |||||
| PUT/CALL Ratio | No data | No data | ||||
| 1 hedge funds and active managers as identified by whalewisdom.com through public filings. | ||||||
Please sign in first
none
none
none
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|---|---|---|---|
|
44,055,000 | 2021-04-21 | 4 | |
|
5,736,250 | 2021-02-08 | 3 | |
|
1,830,610 | 2021-02-08 | 3 | |
|
MACDONALD JAMES J. SEE REMARKS |
|
561,562 | 2021-02-08 | 1 |
|
HARR STEVE PRESIDENT & CEO |
|
8,856,250 | 2021-02-08 | 1 |
|
FLAGSHIP VENTURES FUND V GENERAL PARTNER LLC FLAGSHIP V VENTURELABS RX FUND, L.P. FLAGSHIP VENTURES FUND V, L.P. FLAGSHIP PIONEERING FUND VI GENERAL PARTNER LLC FLAGSHIP PIONEERING FUND VI, L.P. |
|
34,239,018 | 2021-02-08 | 1 |
|
ARCH VENTURE FUND IX OVERAGE, L.P. ARCH VENTURE FUND X OVERAGE, L.P. ARCH VENTURE PARTNERS IX, L.P. ARCH VENTURE PARTNERS IX OVERAGE, L.P. |
|
44,042,500 | 2021-02-08 | 2 |
|
44,042,500 | 2021-02-08 | 2 | |
|
0 | 2021-02-03 | 2 | |
|
0 | 2021-02-03 | 2 | |
|
0 | 2021-02-03 | 2 | |
|
0 | 2021-02-03 | 2 | |
|
0 | 2021-02-03 | 2 | |
|
0 | 2021-02-03 | 2 | |
|
AGARWAL SUNIL SEE REMARKS |
|
0 | 2021-02-03 | 2 |
| Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No current insider transactions | ||||||||||||||||
* -
| Code | Definition |
|---|---|
| A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
| C | Conversion of derivative security |
| D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
| G | Bona fide gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
| J | Other acquisition or disposition |
| L | Small acquisition under Rule 16a-6 |
| M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
| O | Exercise of out-of-the-money derivative security |
| P | Open market or private purchase of non-derivative or derivative security |
| S | Open market or private sale of non-derivative or derivative security |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| W | Acquisition or disposition by will or the laws of descent and distribution |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
| Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
|---|---|---|---|---|
| SANA BIOTECHNOLOGY INC SANA | 2021-07-23 22:15:03 UTC | -0.4975 | 0.5775 | 250000 |
| SANA BIOTECHNOLOGY INC SANA | 2021-07-23 21:45:03 UTC | -0.5482 | 0.6282 | 250000 |
| SANA BIOTECHNOLOGY INC SANA | 2021-07-23 21:15:03 UTC | -0.5482 | 0.6282 | 250000 |
| SANA BIOTECHNOLOGY INC SANA | 2021-07-23 20:45:03 UTC | -0.5756 | 0.6556 | 250000 |
| SANA BIOTECHNOLOGY INC SANA | 2021-07-23 20:15:05 UTC | -0.5756 | 0.6556 | 250000 |
| SANA BIOTECHNOLOGY INC SANA | 2021-07-23 19:45:03 UTC | -0.5756 | 0.6556 | 250000 |
| SANA BIOTECHNOLOGY INC SANA | 2021-07-23 19:15:03 UTC | -0.5756 | 0.6556 | 250000 |
| SANA BIOTECHNOLOGY INC SANA | 2021-07-23 18:45:03 UTC | -0.5534 | 0.6334 | 250000 |
| SANA BIOTECHNOLOGY INC SANA | 2021-07-23 18:15:03 UTC | -0.5534 | 0.6334 | 250000 |
| SANA BIOTECHNOLOGY INC SANA | 2021-07-23 17:45:03 UTC | -0.5534 | 0.6334 | 250000 |
| SANA BIOTECHNOLOGY INC SANA | 2021-07-23 17:15:02 UTC | -0.5534 | 0.6334 | 250000 |
| SANA BIOTECHNOLOGY INC SANA | 2021-07-23 16:45:02 UTC | -0.5534 | 0.6334 | 250000 |
| SANA BIOTECHNOLOGY INC SANA | 2021-07-23 16:15:03 UTC | -0.5534 | 0.6334 | 250000 |
| SANA BIOTECHNOLOGY INC SANA | 2021-07-23 15:45:02 UTC | -0.5534 | 0.6334 | 250000 |
| SANA BIOTECHNOLOGY INC SANA | 2021-07-23 15:15:03 UTC | -0.5534 | 0.6334 | 250000 |
| SANA BIOTECHNOLOGY INC SANA | 2021-07-23 14:45:03 UTC | -0.3982 | 0.4782 | 250000 |
| SANA BIOTECHNOLOGY INC SANA | 2021-07-23 14:15:03 UTC | -0.3982 | 0.4782 | 250000 |
| SANA BIOTECHNOLOGY INC SANA | 2021-07-23 13:45:03 UTC | -0.3982 | 0.4782 | 250000 |
| SANA BIOTECHNOLOGY INC SANA | 2021-07-23 13:15:03 UTC | -0.3982 | 0.4782 | 250000 |
| SANA BIOTECHNOLOGY INC SANA | 2021-07-23 12:45:03 UTC | -0.3982 | 0.4782 | 250000 |
| Holder | Issuer | Net Short Position | Position Date | Origin |
|---|---|---|---|---|
| Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund | SANA | -100.0 shares, $-3347.0 | 2021-03-31 | N-PORT |
| Weiss Strategic Interval Fund- Weiss Strategic Interval Fund | SANA | -1287.0 shares, $-43075.89 | 2021-03-31 | N-PORT |
| Series Portfolios Trust- Weiss Alternative Balanced Risk Fund | SANA | -48.0 shares, $-1032.0 | 2021-04-30 | N-PORT |
| INVESTMENT MANAGERS SERIES TRUST- 361 Domestic Long/Short Equity Fund | SANA | -5705.0 shares, $-122657.5 | 2021-04-30 | N-PORT |
